OLMA Projected Dividend Yield
Olema Pharmaceuticals Inc ( NASDAQ : OLMA )Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the discovery, development, and commercialization of targeted therapies for women's cancers. Its lead product candidate, OP-1250, is an oral therapy with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). Co.'s OP-1250 is an oral small molecule clinical-stage product candidate for the treatment of endocrine-driven cancers. 21 YEAR PERFORMANCE RESULTS |
OLMA Dividend History Detail OLMA Dividend News OLMA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |